Surveillance of Creutzfeldt-Jakob disease in Australia: 2008

Authors

  • Genevieve M Klug Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Alison Boyd Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Victoria Lewis Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Amelia R McGlade Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Helene Roberts Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Samantha L Douglass Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Colin L Masters Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne
  • Steven J Collins Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne

DOI:

https://doi.org/10.33321/cdi.2008.32.21

Keywords:

Australian National Creutzfeldt- Jakob Disease Registry, Creutzfeldt-Jakob disease, disease surveillance, mortality, transmissible spongiform encephalopathies

Abstract

Australia-wide surveillance of all human transmissible spongiform encephalopathies (TSEs) is performed by the Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR), since establishment in October 1993. During the surveillance period 1 April 2007 to 31 March 2008, the ANCJDR received 78 new suspect case notifications of TSEs (67 in 2007, 13 in 2008). This level of suspect case notification aligns with the previous 2006/2007 surveillance period, which was elevated in comparison to the previous 5 years. Based on the total number of probable and definite Creutzfeldt-Jakob disease (CJD) cases, encompassing retrospective cases to 1970 and prospectively ascertained cases from 1993 to 31 March 2008, the average age-adjusted mortality rate is 1.16 deaths per million per year. In this short report, we provide updated Australian TSE figures and describe recent changes in surveillance mechanisms and review their impact on case notifications and eventual CJD classification. Commun Dis Intell 2008;32:232–236.

Downloads

Download data is not yet available.

References

Will RG. Prion related disorders. J R Coll Physicians Lond 1999;33:311–315.

Klug GM, Boyd A, Lewis V, Douglass SL, Roberts H, Argent, R, et al. Creutzfeldt-Jakob disease: Australian surveillance update to March 2007. Commun Dis Intell 2007;31:195–198.

The European and Allied Countries Collaborative Study Group of CJD (EUROCJD). Available from: http://www.eurocjd.ed.ac.uk/results.htm

Downloads

Published

01/06/08

How to Cite

Klug, Genevieve M, Alison Boyd, Victoria Lewis, Amelia R McGlade, Helene Roberts, Samantha L Douglass, Colin L Masters, and Steven J Collins. 2008. “Surveillance of Creutzfeldt-Jakob Disease in Australia: 2008”. Communicable Diseases Intelligence 32 (June):232-36. https://doi.org/10.33321/cdi.2008.32.21.

Issue

Vol. 32 (2008)

Section

Annual report

Categories

License

Copyright (c) 2008 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>